Anaplastic thyroid cancer therapy: dream or reality?

Elisei, Rossella
December 2012
Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p468
Academic Journal
The author discusses the prospects of anaplastic thyroid cancer (ATC) therapy. He mentions that the management of ATC is quiet difficult as patients usually present with both extensive local disease and progressive distant metastases. He further discusses the failure of conventional therapeutic approaches including thyroidectomy, radiotherapy and chemotherapy as the outcomes from these are not satisfactory and are ineffective.


Related Articles

  • Exophytic and Ulcerated Local Recurrence of Papillary Thyroid Carcinoma with Spectacular Response to External Beam Radiotherapy. Anastasios Gkountouvas; Dimitrios Thomas; Athanasia Tertipi; Konstantinos Chrysanthou; Philippos Kaldrimidis // Thyroid;Sep2008, Vol. 18 Issue 9, p1015 

    Summary:A 60-year-old female patient with a history of multifocal papillary thyroid carcinoma was referred to the endocrinology clinic for an exophytic and ulcerated lesion at the right base of the neck. Twelve years earlier she had undergone a total thyroidectomy for multinodular goiter. Four...

  • Safety of completion thyroidectomy for multicentric carcinoma. Rigberg, David; Chandler, Charles; Ashley, Stanley; Zuckerbraun, Lionel; Thompson, Jesse // American Surgeon;Feb1998, Vol. 64 Issue 2, p189 

    Compares the relative safety of a one-stage versus a two-stage approach in the management of thyroid cancer. Why a total thyroidectomy is advocated; Controversy regarding the timing of completion thyroidectomy.

  • Bronchoscopic interventions combined with percutaneous modalities for the treatment of thyroid cancers with airway invasion. Wang, Hongwu; Tao, Meimei; Zhang, Nan; Luo, Lingfei; Li, Dongmei; Zou, Hang; Zhou, Yunzhi; Liang, Sujuan // European Archives of Oto-Rhino-Laryngology;Feb2015, Vol. 272 Issue 2, p445 

    This study was designed to explore the effectiveness and safety of the combination of bronchoscopic interventions and percutaneous modalities in treating thyroid cancers with airway invasion. A total of 13 patients, 5 men and 8 women, were retrospectively included into this study. All patients...

  • OXiGENE Shows Survival Improves in Thyroid Cancer.  // Biotech Business;Jun2012, Vol. 25 Issue 6, p1 

    The article focuses on the announcement of OXiGENE Inc. on the results of the pre-specified subgroup analysis of the FACT trial presented at the 2012 Annual Meeting of the American Association of Endocrine Surgeons (AAES) held in Iowa City. It says that the data showed that patients with...

  • To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients. Carballo, Marilee; Quiros, Roderick M. // Journal of Oncology;2012, p1 

    Radioactive iodine (RAI) is used in treatment of patients with differentiated papillary and follicular thyroid cancer. It is typically used after thyroidectomy, both as a means of imaging to detect residual thyroid tissue or metastatic disease, as well as a means of treatment by ablation if such...

  • SUPPRESSIVE ACYCLOVIR IMPROVES HSV OUTCOMES.  // Contemporary Pediatrics;Nov2011, Vol. 28 Issue 11, p14 

    No abstract available.

  • Left atrial metastasis of Hürthle-cell thyroid carcinoma mimicking myxoma. Giovanella, Luca; Treglia, Giorgio; Ceriani, Luca; Weidner, Sabine; Perriard, Ulrike; Bongiovanni, Massimo // Journal of Nuclear Cardiology;Apr2014, Vol. 21 Issue 2, p406 

    No abstract available.

  • Managing newly diagnosed thyroid cancer. Sawka, Anna M.; Brierley, James D.; Ezzat, Shereen; Goldstein, David P. // CMAJ: Canadian Medical Association Journal;3/4/2014, Vol. 186 Issue 4, p269 

    The article discusses management for patients who are newly diagnosed with thyroid cancer, which is a disease that has an overall five-year survival rate of 98 percent according to nonprofit Cancer Care Ontario. Topics discussed include the evaluation method used in the classification of the...

  • Concurrent chemo and radiation therepy improves long-term survival for inoperable stage III lung cancer.  // Biomedical Market Newsletter;9/12/2011, Vol. 21, p90 

    The article reports on a study published in the "Journal of the National of Cancer Institute" which highlighted that treating patients through concurrent chemotherapy and radiation therapy increases five-year survival rate than compared with radiation therapy after chemotherapy.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics